Kurt H. Kruger - 19 Aug 2021 Form 4 Insider Report for Qualigen Therapeutics, Inc. (QLGN)

Role
Director
Signature
/s/ Hayden Trubitt, Attorney-in-Fact for Kurt H. Kruger
Issuer symbol
QLGN
Transactions as of
19 Aug 2021
Net transactions value
+$9,800
Form type
4
Filing time
20 Aug 2021, 15:05:21 UTC
Next filing
04 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QLGN Common Stock Purchase $4,920 +4,000 +40% $1.23 14,000 19 Aug 2021 Direct
transaction QLGN Common Stock Purchase $4,880 +4,000 +29% $1.22 18,000 19 Aug 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.